En esta página
EBS Emergent BioSolutions Inc. Common Stock
NYSE · Biotechnology · Ver en SEC EDGAR ↗ cerrar Oct 2, 2026 10-K/10-Q Ago 6, 2026
$6,33
· % del rango de 52 semanas
· por encima del mínimo
· a alto
$4,36mínimo 52 semanas
$14,06máximo 52 semanas
Capitalización Bursátil (MRQ)
$325M
P/E (TTM)
-1.8
BPA (TTM)
$-3.46
Ingresos (TTM)
$770M
tus insignias
Rango 52S
$4–$14
Calificación del Analista
BUY
Precio Objetivo
$11
P/E
-1.8
ROE
-40.3%
Margen de Beneficio Neto
-23.0%
Tu barra de insignias está vacía — fija una métrica en cualquier lugar de esta página.
EBS Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$6.33
Capitalización Bursátil (MRQ)
$325M
P/E (TTM)
-1.8
BPA (TTM)
$-3.46
Ingresos (TTM)
$770M
ROE (TTM)
-40.3%
Deuda/Capital (MRQ)
1.7
Rango 52S
$4–$14
EBS Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
rango
barras
La granularidad de las barras se adapta al período seleccionado; pase el ratón sobre el gráfico para ver la apertura/máximo/mínimo/cierre de una barra.
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos$743M2017-12-31 → 2025-12-31
BPA$0.932017-12-31 → 2025-12-31
Flujo de caja libre$157M2017-12-31 → 2025-12-31
Margen neto-23.0%2017-12-31 → 2025-12-31
Valoración y ratios
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
| Métrica | Tendencia a 5 años | EBS | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| P/E (TTM) | -1.8promedio 5A ≈1.9 | ≈1.9 | · | · | |
| P/S (TTM) | 0.4promedio 5A ≈0.5 | ≈0.5 | 25.7 | Infravalorado | |
| P/C (MRQ) | 1.0promedio 5A ≈0.8 | ≈0.8 | 2.5 | Infravalorado | |
| EV / EBITDA | 3.6promedio 5A ≈3612.0 | ≈3612.0 | · | · | |
| Precio / FCF (TTM) | 3.8promedio 5A ≈6.0 | ≈6.0 | · | · | |
| Precio / Flujo de Caja (TTM) | 3.3promedio 5A ≈4.0 | ≈4.0 | · | · | |
| EV / Revenue (EV / Ingresos) | 0.9promedio 5A ≈1.2 | ≈1.2 | · | · | |
| EV / FCF | 4.4promedio 5A ≈10.6 | ≈10.6 | · | · | |
| Precio / Valor Contable Tangible (MRQ) | 4.1promedio 5A ≈3.4 | ≈3.4 | · | · |
La mediana de empresas comparables se calcula sobre una base estandarizada por métrica y puede no coincidir siempre con la base TTM/MRQ que se muestra para esta acción.
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
| Métrica | Tendencia a 5 años | EBS | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Margen Operativo (TTM) | -8.6%promedio 5A ≈-20.3% | ≈-20.3% | -209.1% | De primer nivel | |
| Margen EBITDA (TTM) | 3.7%promedio 5A ≈-11.5% | ≈-11.5% | -209.1% | De primer nivel | |
| Margen antes de impuestos (TTM) | -19.0%promedio 5A ≈-23.0% | ≈-23.0% | -245.7% | De primer nivel | |
| Margen de Beneficio Neto (TTM) | -23.0%promedio 5A ≈-25.7% | ≈-25.7% | -246.0% | De primer nivel | |
| ROA (TTM) | -14.0%promedio 5A ≈-12.8% | ≈-12.8% | -49.3% | De primer nivel | |
| ROE (TTM) | -40.3%promedio 5A ≈-47.2% | ≈-47.2% | -64.8% | De primer nivel | |
| ROIC | 5.8%promedio 5A ≈-15.4% | ≈-15.4% | -100.1% | De primer nivel |
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
| Métrica | Tendencia a 5 años | EBS | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Deuda / Patrimonio (MRQ) | 1.7promedio 5A ≈1.5 | ≈1.5 | · | · | |
| Ratio corriente (MRQ) | 5.4promedio 5A ≈3.2 | ≈3.2 | 5.1 | En línea | |
| Quick Ratio (Ratio Rápido) | 2.2promedio 5A ≈1.4 | ≈1.4 | 2.9 | Baja liquidez | |
| Deuda a Largo Plazo / Patrimonio (MRQ) | 1.7promedio 5A ≈1.1 | ≈1.1 | · | · |
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
| Métrica | Tendencia a 5 años | EBS | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Revenue YoY (Ingresos interanuales) | -28.8%promedio 5A ≈-18.1% | ≈-18.1% | · | · | |
| Revenue CAGR 3Y (Ingresos CAGR 3A) | -12.7%promedio 5A ≈-13.9% | ≈-13.9% | · | · | |
| Revenue CAGR 5Y (Ingresos CAGR 5A) | -14.0% | · | · | · | |
| EPS CAGR 5Y (CAGR BPA 5A) | -30.4% | · | · | · | |
| Net Income CAGR 5Y (CAGR Beneficio Neto 5A) | -29.7% | · | · | · |
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
| Métrica | Tendencia a 5 años | EBS | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Asset Turnover (Rotación de Activos) | 0.5promedio 5A ≈0.5 | ≈0.5 | 0.1 | De primer nivel | |
| Inventory Turnover (Rotación de Inventario) | 1.0 | · | · | · | |
| Receivables Turnover (Rotación de Cuentas por Cobrar) | 6.2promedio 5A ≈6.1 | ≈6.1 | 2.6 | De primer nivel | |
| Revenue / Employee (Ingresos / Empleado) | ≈$825.4K | · | · | · |
valor · ≈ promedio 5A · mediana sectorial · veredicto relativo a la mediana
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
217.1%
Próximo informe
Oct 27, 2026
| Período | Informe | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|---|
| 30 de junio de 2026 | Ago 11, 2026 | $0.60 | $0.11 | 440.1% |
| 31 de marzo de 2026 | May 13, 2026 | $0.21 | $-0.25 | 183.2% |
| 31 de diciembre de 2025 | $-0.43 | $0.11 | -487.0% | |
| 30 de septiembre de 2025 | $1.06 | $-0.12 | 974.6% | |
| 30 de junio de 2025 | $0.16 | $-0.49 | 132.3% | |
| 31 de marzo de 2025 | $0.71 | $0.44 | 59.8% |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $743M | $1.04B | $1.05B | $1.12B | $1.77B | $1.58B | $1.11B | $782M | $561M | $489M | $489M | $404M | |
| Cost of Revenue | $326M | $681M | $705M | $693M | $748M | $537M | $434M | $322M | $188M | $126M | $107M | $102M | |
| Gross Profit | · | · | $318M | $383M | $891M | $925M | · | · | · | · | · | · | |
| R&D Expense | $53M | $71M | $111M | $188M | $235M | $238M | $226M | $143M | $97M | $107M | $119M | $105M | |
| SG&A Expense | $186M | $308M | $368M | $340M | $349M | $304M | $274M | $202M | $143M | $143M | $121M | $109M | |
| Operating Expenses | · | · | · | · | · | · | $992M | $693M | $437M | $383M | · | · | |
| Operating Income | $100M | $-109M | $-726M | $-170M | $341M | $438M | $114M | $90M | $124M | $106M | $142M | $89M | |
| Interest Expense | · | · | $88M | $37M | $34M | $31M | $38M | $10M | $7M | $8M | $7M | $8M | |
| Interest Income | · | · | · | · | · | · | · | · | $2M | $1M | $572.0K | $320.0K | |
| Other Non-op | $54M | $12M | $6M | $-12M | $-4M | $5M | $2M | $2M | $900.0K | $1M | $153.0K | $3M | |
| Pretax Income | $83M | $-143M | $-731M | $-219M | $303M | $412M | $77M | $82M | $119M | $99M | $136M | $84M | |
| Income Tax | $30M | $48M | $29M | $-7M | $84M | $106M | $23M | $19M | $36M | $37M | $44M | $30M | |
| Net Income | $53M | $-191M | $-760M | $-212M | $220M | $306M | $54M | $63M | $83M | $52M | $63M | $37M | |
| EPS (Basic) | $0.98 | $-3.60 | $-14.85 | $-4.22 | $4.10 | $5.80 | $1.06 | $1.25 | $1.98 | $1.29 | $1.63 | $0.98 | |
| EPS (Diluted) | $0.93 | $-3.60 | $-14.85 | $-4.22 | $4.06 | $5.68 | $1.04 | $1.22 | $1.71 | $1.13 | $1.41 | $0.88 | |
| Shares (Basic) | 53,500,000 | 53,000,000 | 51,200,000 | 50,100,000 | 53,500,000 | 52,700,000 | 51,500,000 | 50,100,000 | 41,800,000 | 40,200,000 | 38,595,435 | 37,344,891 | |
| Shares (Diluted) | 56,700,000 | 53,000,000 | 51,200,000 | 50,100,000 | 54,100,000 | 53,800,000 | 52,400,000 | 51,400,000 | 50,300,000 | 49,300,000 | 47,255,842 | 45,802,807 | |
| EBITDA | $196M | $100.0K | $-601M | $-170M | $353M | $484M | $164M | $126M | $157M | $134M | $121M | $81M |
Balance general
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $205M | $100M | $112M | $643M | $576M | $621M | $168M | $112M | $178M | $272M | $313M | $280M | |
| Receivables | $84M | $154M | $191M | $159M | $279M | $231M | $271M | $262M | $144M | $138M | $114M | $59M | |
| Inventory | $343M | $312M | $329M | $351M | $344M | $307M | $222M | $206M | $143M | $74M | $61M | $66M | |
| Prepaid Expense | $26M | $27M | $48M | $58M | $70M | $36M | $25M | $32M | $17M | $16M | $18M | $24M | |
| Current Assets | $662M | $599M | $680M | $1.21B | $1.27B | $1.20B | $686M | $621M | $485M | $510M | $537M | $432M | |
| PP&E (Net) | $205M | $271M | $383M | $818M | $800M | $644M | $542M | $510M | $407M | $376M | $328M | $314M | |
| PP&E (Gross) | $510M | $668M | $794M | $1.20B | $1.12B | $903M | $753M | $682M | $540M | $488M | $422M | $393M | |
| Accum. Depreciation | $304M | $397M | $411M | $384M | $319M | $259M | $210M | $172M | $132M | $112M | $94M | $79M | |
| Goodwill | $0 | $0 | $0 | $218M | $225M | $267M | $267M | $260M | $49M | $41M | $41M | $53M | |
| Intangibles | $436M | $502M | $567M | $729M | $605M | $663M | $713M | $762M | $120M | $34M | $41M | $58M | |
| Other Non-current Assets | $14M | $19M | $194M | $191M | $58M | $113M | $90M | $14M | $6M | $2M | $2M | $8M | |
| Total Assets | $1.32B | $1.39B | $1.82B | $3.17B | $2.96B | $2.88B | $2.33B | $2.23B | $1.07B | $970M | $1.04B | $939M | |
| Accounts Payable | $56M | $61M | $112M | $104M | $129M | $136M | $95M | $81M | $42M | $35M | $38M | $41M | |
| Accrued Liabilities | $12M | $18M | $19M | $35M | $52M | $47M | $40M | $31M | $5M | $6M | $6M | $6M | |
| Short-term Debt | · | $0 | $414M | $957M | $32M | $34M | $13M | $10M | $0 | $20M | $0 | · | |
| Current Liabilities | $132M | $162M | $651M | $1.23B | $374M | $384M | $216M | $200M | $100M | $106M | $100M | $93M | |
| Capital Leases | $9M | $10M | $14M | $15M | $24M | $28M | $22M | · | · | · | · | · | |
| Deferred Tax | $38M | $42M | $47M | $60M | $93M | $53M | $64M | $68M | $0 | · | · | · | |
| Other Non-current Liabilities | $54M | $39M | $29M | $42M | $70M | $68M | $49M | $49M | $5M | $2M | $1M | $1M | |
| Total Liabilities | $796M | $907M | $1.17B | $1.78B | $1.35B | $1.44B | $1.24B | $1.22B | $158M | $374M | $377M | $385M | |
| Long-term Debt | $590M | $700M | $868M | $1.41B | $850M | $886M | $822M | $809M | $14M | · | · | · | |
| Total Debt | $572M | $664M | $1.27B | · | $873M | $909M | $824M | $805M | $13M | $268M | $253M | $251M | |
| Common Stock | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $41.0K | $40.0K | $38.0K | |
| Paid-in Capital | $942M | $928M | $904M | $874M | $829M | $785M | $716M | $689M | $618M | $352M | $318M | $274M | |
| Retained Earnings | $-160M | $-212M | $-22M | $739M | $950M | $727M | $422M | $367M | $337M | $254M | $351M | $288M | |
| Treasury Stock | $253M | $228M | $228M | $228M | $152M | $40M | $40M | $40M | $40M | $6M | $6M | $6M | |
| AOCI | $-8M | $-5M | $-6M | $3M | $-16M | $-25M | $-10M | $-6M | $-4M | $-4M | $-3M | $-3M | |
| Stockholders' Equity | $523M | $483M | $649M | $1.39B | $1.61B | $1.45B | $1.09B | $1.01B | $912M | $596M | $660M | $553M | |
| Liabilities + Equity | $1.32B | $1.39B | $1.82B | $3.17B | $2.96B | $2.88B | $2.33B | $2.23B | $1.07B | $970M | $1.04B | $939M | |
| Shares Outstanding | 52,100,000 | 54,300,000 | 52,200,000 | 50,100,000 | 51,300,000 | 54,300,000 | 51,700,000 | 51,200,000 | 49,400,000 | 41,000,000 | 39,800,000 | 38,129,872 |
Flujo de Efectivo
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $96M | $109M | $125M | $143M | $124M | $50M | $50M | $36M | $32M | $28M | $24M | $22M | |
| Stock-based Comp | $16M | $18M | $23M | $45M | $42M | $52M | $27M | $23M | $15M | $18M | $16M | $13M | |
| Deferred Tax | $-4M | $-6M | $-7M | $-34M | $43M | $-3M | $-1M | $9M | $3M | $5M | $3M | $16M | |
| Amort. of Intangibles | $65M | $65M | $66M | $60M | $58M | $60M | $59M | $25M | $9M | $7M | $7M | $7M | |
| Restructuring | $-2M | $22M | $29M | · | · | · | · | · | · | · | · | $0 | |
| Other Non-cash | $10M | $128M | $413M | · | · | $132M | $58M | $-89M | $75M | $-50M | $-62M | $23M | |
| Operating Cash Flow | $171M | $59M | $-206M | $-34M | $320M | $537M | $188M | $42M | $208M | $55M | $43M | $112M | |
| CapEx | $14M | $23M | $52M | $116M | $224M | $142M | $87M | $72M | $55M | $76M | $45M | $31M | |
| Investing Cash Flow | $69M | $125M | $212M | $-381M | $-224M | $-152M | $-97M | $-897M | $-250M | $-76M | $-45M | $-210M | |
| Debt Issued | · | · | · | · | · | · | · | $798M | $0 | $0 | $2M | $1M | |
| Net Debt Issued | · | · | · | · | · | · | · | $795M | $0 | $0 | $0 | $-62M | |
| Stock Issued | $0 | $0 | $8M | $0 | $0 | · | · | · | · | · | · | · | |
| Stock Repurchased | $25M | $0 | $0 | $82M | $106M | $0 | $0 | $100.0K | $33M | $0 | $100.0K | $200.0K | |
| Net Stock Activity | $-25M | $0 | $8M | $-82M | $-106M | $0 | $0 | $-100.0K | $-33M | $0 | $-100.0K | $-200.0K | |
| Financing Cash Flow | $-137M | $-190M | $-536M | $481M | $-141M | $70M | $-36M | $789M | $-51M | $-20M | $35M | $199M | |
| Net Change in Cash | $104M | $-6M | $-531M | $66M | $-45M | $454M | $56M | $-67M | $-93M | $-41M | $32M | $101M | |
| Taxes Paid | $40M | · | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $157M | $36M | $-258M | $-150M | $96M | $395M | $101M | $-30M | $153M | $-23M | $-353.0K | $82M | |
| Levered FCF | · | · | $-349M | $-186M | $71M | $372M | $74M | $-38M | $149M | $-28M | $-5M | $76M |
Rentabilidad
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | 30.3% | 34.3% | · | · | · | · | · | · | · | · | |
| Operating Margin | 13.5% | -10.4% | -69.2% | -15.2% | 19.7% | 27.9% | 10.3% | 11.5% | 22.2% | 21.6% | 18.4% | 12.9% | |
| Net Margin | 7.1% | -18.3% | -72.5% | -18.9% | 12.9% | 19.6% | 4.9% | 8.0% | 14.7% | 10.6% | 12.0% | 8.2% | |
| Pretax Margin | 11.2% | -13.7% | -69.7% | -19.6% | 17.5% | 26.2% | 7.0% | 10.4% | 21.1% | 20.3% | 17.2% | 11.8% | |
| EBITDA Margin | 26.4% | 0.01% | -57.3% | -15.2% | 19.7% | 31.1% | 14.8% | 16.1% | 27.9% | 27.3% | 23.1% | 18.0% | |
| ROA | 3.9% | -11.9% | -30.5% | · | 7.9% | 11.7% | 2.4% | 3.8% | 8.1% | 5.2% | 6.4% | 4.7% | |
| ROE | 9.9% | -38.5% | -113.0% | · | 14.7% | 22.6% | 5.1% | 6.3% | 10.9% | 8.2% | 10.4% | 7.0% | |
| ROIC | 5.8% | -12.7% | -39.3% | · | 10.4% | 13.8% | 4.2% | 3.8% | 9.3% | 7.7% | 7.4% | 5.0% |
Liquidez y Solvencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.0 | 3.7 | 1.0 | · | 3.4 | 3.1 | 3.2 | 3.1 | 4.9 | 4.8 | 5.4 | 4.7 | |
| Quick Ratio | 2.2 | 1.6 | 0.5 | · | 2.3 | 2.2 | 2.0 | 1.9 | 3.2 | 3.9 | 4.4 | 3.7 | |
| Debt / Equity | 1.1 | 1.4 | 2.0 | · | 0.5 | 0.6 | 0.8 | 0.8 | 0.0 | 0.4 | 0.4 | 0.5 | |
| LT Debt / Equity | 1.1 | 1.4 | 0.7 | · | 0.5 | 0.6 | 0.7 | 0.8 | 0.0 | 0.4 | 0.4 | 0.5 | |
| Interest Coverage | · | · | -8.3 | -4.6 | 10.2 | 13.9 | 3.0 | 9.1 | 18.9 | 13.9 | 14.7 | 7.0 |
Eficiencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | 0.6 | 0.4 | · | 0.6 | 0.6 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.6 | |
| Inventory Turnover | 1.0 | · | 2.1 | · | · | 2.0 | 2.0 | 1.8 | 1.8 | 1.9 | 1.7 | 2.9 | |
| Receivables Turnover | 6.2 | 6.0 | 6.0 | · | 7.1 | 6.2 | 4.1 | 3.9 | 4.0 | 3.9 | 5.8 | 7.5 |
Por Acción
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $10.03 | $8.89 | $12.44 | · | $31.56 | $27.25 | $21.05 | $19.74 | $18.47 | $14.69 | $16.75 | $14.67 | |
| Revenue / Share | $13.10 | $19.69 | $20.49 | $22.31 | $33.14 | $28.91 | $21.11 | $15.22 | $11.14 | $9.91 | $11.06 | $9.83 | |
| Cash Flow / Share | $3.01 | $1.11 | $-4.03 | $-0.68 | $5.94 | $9.96 | $3.59 | $0.81 | $4.14 | $1.08 | $0.94 | $2.45 | |
| Cash / Share | $3.94 | $1.83 | $2.14 | · | $11.23 | $11.70 | $3.25 | $2.19 | $3.61 | $6.69 | $7.94 | $7.44 | |
| EPS (TTM) | $0.93 | $-3.60 | $-14.85 | $-4.22 | $4.06 | $5.68 | $1.04 | $1.22 | $1.71 | $1.13 | $1.41 | $0.88 |
Tasas de Crecimiento
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -28.8% | -0.54% | -6.1% | -37.0% | 12.4% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -12.7% | -16.2% | -12.7% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | -14.0% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | · | · | · | · | -28.5% | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | -30.4% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | · | · | · | · | -28.2% | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -29.7% | · | · | · | · | · | · | · | · | · | · | · |
Valoración (TTM)
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $743M | $1.04B | $1.05B | $1.12B | $1.77B | $1.58B | $1.11B | $782M | $561M | $489M | $489M | $404M | |
| Net Income TTM | $53M | $-191M | $-760M | $-212M | $220M | $306M | $54M | $63M | $83M | $52M | $63M | $37M | |
| Market Cap | $644M | $519M | $125M | · | $2.23B | $4.76B | $2.79B | $3.04B | $2.30B | $1.33B | $1.58B | $1.03B | |
| Enterprise Value | $1.01B | $1.08B | $1.29B | · | $2.53B | $5.05B | $3.45B | $3.73B | $2.13B | $1.33B | $1.52B | $997M | |
| P/E | 13.3 | -2.7 | -0.2 | -2.8 | 10.7 | 15.8 | 51.9 | 48.6 | 27.2 | 29.1 | 28.4 | 30.9 | |
| P/S | 0.9 | 0.5 | 0.1 | · | 1.3 | 3.0 | 2.5 | 3.9 | 4.1 | 2.7 | 3.2 | 2.5 | |
| P/B | 1.2 | 1.1 | 0.2 | · | 1.4 | 3.3 | 2.6 | 3.0 | 2.5 | 2.2 | 2.4 | 1.9 | |
| P / Tangible Book | 7.5 | · | 1.5 | 1.3 | 2.9 | 9.1 | · | · | · | · | · | · | |
| P / Cash Flow | 3.8 | 8.8 | -0.6 | · | 6.9 | 8.9 | 14.8 | 72.6 | 11.0 | 24.9 | 35.5 | 9.1 | |
| P / FCF | 4.1 | 14.5 | -0.5 | · | 23.2 | 12.0 | 27.6 | -100.2 | 15.0 | -58.5 | -4466.5 | 12.6 | |
| EV / EBITDA | 5.2 | 10833.1 | -2.1 | · | 7.2 | 10.4 | 21.1 | 29.6 | 13.6 | 10.0 | 12.6 | 12.3 | |
| EV / FCF | 6.4 | 30.3 | -5.0 | · | 26.3 | 12.8 | 34.1 | -123.0 | 13.9 | -58.4 | -4297.1 | 12.2 | |
| EV / Revenue | 1.4 | 1.0 | 1.2 | · | 1.4 | 3.2 | 3.1 | 4.8 | 3.8 | 2.7 | 3.1 | 2.5 | |
| Earnings Yield | 7.5% | -37.7% | -618.8% | -35.7% | 9.3% | 6.3% | 1.9% | 2.1% | 3.7% | 3.4% | 3.5% | 3.2% |
Estado de resultados
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $234M | $156M | $149M | $231M | $141M | $222M | $195M | $294M | $255M | $300M | $277M | $270M | $338M | $164M | $330M | $240M | |
| Cost of Revenue | $97M | $72M | $85M | $86M | $67M | $88M | $118M | $123M | $296M | $145M | $185M | $177M | $191M | $153M | · | $147M | |
| Gross Profit | · | · | · | · | · | · | · | $161M | $-48M | $148M | · | $87M | $141M | $5M | · | $75M | |
| R&D Expense | $9M | $10M | $12M | $14M | $12M | $15M | $9M | $14M | $33M | $15M | $29M | $15M | $26M | $41M | $50M | $42M | |
| SG&A Expense | $45M | $47M | $51M | $39M | $44M | $52M | $61M | $77M | $86M | $85M | $90M | $86M | $91M | $101M | $92M | $82M | |
| Operating Income | $-125M | $10M | $-28M | $76M | $2M | $50M | $-10M | $64M | $-204M | $40M | $-44M | $-242M | $-293M | $-148M | $-55M | $-45M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $24M | · | $20M | $29M | $18M | · | $8M | |
| Other Non-op | $0 | $14M | $-8M | $-4M | $-4M | $70M | $-4M | $22M | $-3M | $-3M | $8M | $-3M | $-4M | $5M | $7M | $-13M | |
| Pretax Income | $-166M | $13M | $-51M | $58M | $-17M | $93M | $-28M | $142M | $-270M | $12M | $-54M | $-266M | $-250M | $-161M | $-65M | $-67M | |
| Income Tax | $14M | $7M | $4M | $6M | $-5M | $25M | $4M | $28M | $13M | $3M | $-5M | $-2M | $11M | $26M | $-800.0K | $20M | |
| Net Income | $-180M | $7M | $-55M | $51M | $-12M | $68M | $-31M | $115M | $-283M | $9M | $-50M | $-263M | $-261M | $-186M | $-67M | $-87M | |
| EPS (Basic) | $-3.49 | $0.13 | $-1.01 | $0.96 | $-0.22 | $1.25 | $-0.55 | $2.16 | $-5.38 | $0.17 | $-0.90 | $-5.08 | $-5.16 | $-3.71 | $-1.32 | $-1.75 | |
| EPS (Diluted) | $-3.49 | $0.07 | $-0.95 | $0.91 | $-0.22 | $1.19 | $-0.45 | $2.06 | $-5.38 | $0.17 | $-0.90 | $-5.08 | $-5.16 | $-3.71 | $-1.32 | $-1.75 | |
| Shares (Basic) | 51,600,000 | 51,900,000 | · | 53,200,000 | 54,200,000 | 54,400,000 | · | 53,100,000 | 52,600,000 | 52,200,000 | · | 51,800,000 | 50,700,000 | 50,200,000 | · | 49,900,000 | |
| Shares (Diluted) | 51,600,000 | 56,500,000 | · | 56,500,000 | 54,200,000 | 57,300,000 | · | 55,600,000 | 52,600,000 | 52,200,000 | · | 51,800,000 | 50,700,000 | 50,200,000 | · | 49,900,000 | |
| EBITDA | $-125M | $34M | · | $76M | $2M | $75M | · | $64M | $-204M | $68M | · | $-242M | $-293M | $-114M | · | $-42M |
Balance general
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $140M | $160M | $205M | $246M | $267M | $149M | $100M | $150M | $70M | $78M | $112M | $88M | $89M | $430M | $643M | $241M | |
| Receivables | $190M | $122M | $84M | $150M | $80M | $204M | $154M | $121M | $196M | $234M | · | $216M | $290M | $156M | · | $191M | |
| Inventory | $304M | $328M | $343M | $356M | $339M | $314M | $312M | $323M | $318M | $333M | · | $354M | $354M | $368M | · | $546M | |
| Prepaid Expense | $25M | $27M | $26M | $26M | $24M | $30M | $27M | $61M | $36M | $36M | · | $62M | $45M | $42M | · | $140M | |
| Current Assets | $666M | $638M | $662M | $787M | $720M | $707M | $599M | $661M | $654M | $682M | · | $721M | $778M | $1.22B | · | $1.12B | |
| PP&E (Net) | $178M | $199M | $205M | $210M | $216M | $221M | $271M | $278M | $306M | $379M | · | $395M | $396M | $717M | · | $807M | |
| PP&E (Gross) | $475M | $509M | $510M | $500M | $516M | $518M | $668M | $672M | $707M | $802M | · | $796M | $787M | $1.09B | · | $1.17B | |
| Accum. Depreciation | $297M | $310M | $304M | $291M | $300M | $297M | $397M | $394M | $401M | $423M | · | $401M | $391M | $375M | · | $366M | |
| Goodwill | · | · | $0 | · | · | · | $0 | $0 | $0 | $0 | $0 | $0 | $218M | $218M | · | $225M | |
| Intangibles | $262M | $470M | $436M | $453M | $469M | $485M | $502M | $518M | $534M | $550M | · | $583M | $593M | $609M | · | $723M | |
| Other Non-current Assets | $11M | $13M | $14M | $12M | $12M | $13M | $19M | $20M | $19M | $191M | · | $194M | $195M | $185M | · | $36M | |
| Total Assets | $1.12B | $1.32B | $1.32B | $1.46B | $1.42B | $1.43B | $1.39B | $1.48B | $1.51B | $1.80B | · | $1.89B | $2.18B | $2.95B | · | $2.91B | |
| Accounts Payable | $50M | $40M | $56M | $57M | $64M | $58M | $61M | $82M | $96M | $100M | · | $113M | $108M | $124M | · | $104M | |
| Accrued Liabilities | $17M | $9M | $12M | $14M | $14M | $13M | $18M | $16M | $17M | $14M | · | $17M | $31M | $21M | · | $36M | |
| Short-term Debt | · | · | · | · | · | · | · | $800.0K | $415M | $459M | · | $414M | $455M | $951M | · | $21M | |
| Current Liabilities | $123M | $149M | $132M | $136M | $127M | $112M | $162M | $230M | $620M | $630M | · | $664M | $693M | $1.22B | · | $268M | |
| Capital Leases | $5M | $9M | $9M | $6M | $6M | $5M | $10M | $11M | $12M | $13M | · | $15M | $13M | $13M | · | $16M | |
| Deferred Tax | $35M | $33M | $38M | $36M | $46M | $60M | $42M | $42M | $35M | $35M | · | $52M | $58M | $60M | · | $114M | |
| Other Non-current Liabilities | $35M | $42M | $54M | $43M | $40M | $35M | $39M | $36M | $26M | $28M | · | $31M | $23M | $24M | · | $45M | |
| Total Liabilities | $775M | $797M | $796M | $878M | $881M | $873M | $907M | $969M | $1.13B | $1.14B | · | $1.20B | $1.22B | $1.75B | · | $1.46B | |
| Long-term Debt | $590M | $590M | $590M | $693M | $700M | $700M | $700M | $701M | $864M | $909M | · | $866M | $909M | $1.41B | · | $1.06B | |
| Total Debt | $582M | $574M | · | $663M | $668M | $666M | · | $663M | $1.28B | $1.37B | · | $1.28B | $1.36B | $2.35B | · | $1.07B | |
| Common Stock | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | · | $100.0K | $100.0K | $100.0K | · | $100.0K | |
| Paid-in Capital | $952M | $944M | $942M | $939M | $935M | $931M | $928M | $924M | $915M | $910M | · | $900M | $896M | $878M | · | $860M | |
| Retained Earnings | $-333M | $-153M | $-160M | $-105M | $-156M | $-144M | $-212M | $-181M | $-296M | $-13M | · | $28M | $290M | $551M | · | $822M | |
| Treasury Stock | $270M | $262M | $253M | $244M | $235M | $228M | $228M | $228M | $228M | $228M | · | $228M | $228M | $228M | · | $228M | |
| AOCI | $-7M | $-7M | $-8M | $-8M | $-8M | $-6M | $-5M | $-7M | $-6M | $-6M | · | $-3M | $-2M | $1M | · | $-5M | |
| Stockholders' Equity | $341M | $523M | $523M | $582M | $536M | $553M | $483M | $508M | $386M | $664M | $649M | $697M | $956M | $1.20B | $1.39B | $1.45B | |
| Liabilities + Equity | $1.12B | $1.32B | $1.32B | $1.46B | $1.42B | $1.43B | $1.39B | $1.48B | $1.51B | $1.80B | · | $1.89B | $2.18B | $2.95B | · | $2.91B | |
| Shares Outstanding | 51,300,000 | 51,800,000 | 52,100,000 | 52,700,000 | 53,700,000 | 54,500,000 | 54,300,000 | 54,100,000 | 52,900,000 | 52,400,000 | · | 51,800,000 | 51,800,000 | 50,400,000 | · | 49,900,000 |
Flujo de Efectivo
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $24M | $24M | $24M | $23M | $24M | $25M | $26M | $26M | $28M | $28M | $30M | $28M | $33M | $35M | $36M | $32M | |
| Stock-based Comp | $7M | $2M | $5M | $5M | $5M | $2M | $4M | $2M | $6M | $6M | $4M | $4M | $8M | $7M | $12M | $11M | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $-57M | $20M | |
| Amort. of Intangibles | $17M | $16M | $16M | $16M | $16M | $16M | $16M | $16M | $16M | $16M | $16M | $16M | $16M | $17M | $18M | $14M | |
| Restructuring | · | · | $0 | $300.0K | $-1M | $-1M | $-400.0K | $6M | $17M | $-500.0K | $-600.0K | $20M | $-100.0K | $10M | · | · | |
| Other Non-cash | · | $-66M | · | · | · | $-106M | · | · | · | $-105M | · | · | · | $-42M | · | · | |
| Operating Cash Flow | $56M | $-34M | $78M | $-2M | $106M | $-11M | $-80M | $154M | $48M | $-63M | $32M | $60M | $-114M | $-184M | $93M | $-74M | |
| CapEx | $2M | $2M | $4M | $3M | $3M | $4M | $2M | $6M | $5M | $11M | $11M | $13M | $12M | $15M | $24M | $28M | |
| Investing Cash Flow | $-52M | $-2M | $-4M | $-3M | $17M | $60M | $29M | $112M | $-5M | $-11M | $-11M | $-19M | $258M | $-15M | $-45M | $-272M | |
| Stock Issued | · | $400.0K | $-1M | · | · | $0 | $0 | $0 | · | · | $200.0K | $0 | · | · | $0 | $0 | |
| Stock Repurchased | $9M | $9M | $9M | $9M | $7M | $0 | $0 | $0 | · | · | $0 | $0 | $0 | $0 | $200.0K | $0 | |
| Net Stock Activity | · | $-9M | · | · | · | · | · | · | · | · | · | · | · | $0 | · | · | |
| Financing Cash Flow | $-24M | $-11M | $-114M | $-16M | $-6M | $-400.0K | $500.0K | $-180M | $-51M | $41M | $5M | $-43M | $-487M | $-10M | $353M | $229M | |
| Net Change in Cash | $-21M | $-48M | $-40M | $-22M | $118M | $47M | $-51M | $85M | $-8M | $-33M | $24M | $-800.0K | $-344M | $-210M | $402M | $-117M | |
| Free Cash Flow | · | $-36M | · | · | · | $-15M | · | · | · | $-73M | · | · | · | $-199M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $-91M | · | · | · | $-219M | · | · |
Rentabilidad
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | · | · | 54.9% | -18.9% | 49.2% | · | 32.2% | 41.6% | 2.1% | · | 30.8% | |
| Operating Margin | -53.4% | 6.7% | · | 33.1% | 1.1% | 22.5% | · | 21.9% | -79.9% | 13.2% | · | -89.5% | -86.7% | -89.7% | · | -17.5% | |
| Net Margin | -76.9% | 4.4% | · | 22.1% | -8.5% | 30.6% | · | 39.1% | -111.1% | 3.0% | · | -97.4% | -77.3% | -110.8% | · | -31.5% | |
| Pretax Margin | -71.0% | 8.6% | · | 24.9% | -11.9% | 41.7% | · | 48.5% | -105.9% | 4.0% | · | -98.3% | -74.1% | -97.6% | · | -26.6% | |
| EBITDA Margin | -53.4% | 21.8% | · | 33.1% | 1.1% | 33.9% | · | 21.9% | -79.9% | 22.5% | · | -89.5% | -86.7% | -68.8% | · | -17.5% | |
| ROA | -14.2% | 0.50% | · | 3.5% | -0.82% | 4.2% | · | 6.8% | -15.3% | 0.38% | · | -11.0% | -10.6% | -6.4% | · | -2.6% | |
| ROE | -41.1% | 1.3% | · | 9.4% | -2.6% | 11.2% | · | 19.0% | -42.2% | 0.96% | · | -24.5% | -21.2% | -13.2% | · | -5.1% | |
| ROIC | -14.7% | 0.49% | · | 5.5% | 0.09% | 3.0% | · | 4.4% | -12.8% | 1.5% | · | -12.2% | -13.2% | -4.7% | · | -2.0% |
Liquidez y Solvencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.4 | 4.3 | · | 5.8 | 5.7 | 6.3 | · | 2.9 | 1.1 | 1.1 | · | 1.1 | 1.1 | 1.0 | · | 4.2 | |
| Quick Ratio | 2.7 | 1.9 | · | 2.9 | 2.7 | 3.2 | · | 1.2 | 0.4 | 0.5 | · | 0.5 | 0.5 | 0.5 | · | 1.6 | |
| Debt / Equity | 1.7 | 1.1 | · | 1.1 | 1.2 | 1.2 | · | 1.3 | 3.3 | 2.1 | · | 1.8 | 1.4 | 2.0 | · | 0.7 | |
| LT Debt / Equity | 1.7 | 1.1 | · | 1.1 | 1.2 | 1.2 | · | 1.3 | 1.2 | 0.7 | · | 0.6 | 0.5 | 0.4 | · | 0.7 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 1.6 | · | -12.3 | -10.2 | -8.3 | · | -4.9 |
Eficiencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.1 | · | 0.2 | 0.1 | 0.1 | · | 0.2 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.3 | 0.2 | · | 0.3 | 0.2 | 0.3 | · | 0.4 | 0.9 | 0.4 | · | 0.4 | 0.5 | 0.4 | · | · | |
| Receivables Turnover | 1.7 | 1.0 | · | 1.7 | 1.0 | 1.0 | · | 1.7 | 1.0 | 1.5 | · | 1.3 | 1.5 | 1.0 | · | 1.1 |
Por Acción
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $6.66 | $10.10 | · | $11.05 | $9.99 | $10.14 | · | $9.40 | $7.30 | $12.67 | · | $13.46 | $18.46 | $23.86 | · | $29.04 | |
| Revenue / Share | $4.54 | $2.76 | · | $4.09 | $2.60 | $3.88 | · | $5.28 | $4.84 | $5.75 | · | $5.22 | $6.66 | $3.29 | · | $4.81 | |
| Cash Flow / Share | · | $-0.60 | · | · | · | $-0.20 | · | · | · | $-1.20 | · | · | · | $-3.67 | · | · | |
| Cash / Share | $2.72 | $3.09 | · | $4.66 | $4.98 | $2.74 | · | $2.77 | $1.32 | $1.50 | · | $1.70 | $1.71 | $8.54 | · | $4.83 | |
| EPS (TTM) | $-3.46 | $-0.19 | · | $1.43 | $2.58 | $-2.58 | · | $-4.05 | $-11.19 | $-10.97 | · | $-15.27 | $-11.94 | $-7.84 | · | $0.40 |
Valoración (TTM)
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $770M | $677M | · | $789M | $852M | $965M | · | $1.13B | $1.10B | $1.19B | · | $1.10B | $1.07B | $977M | · | $1.49B | |
| Net Income TTM | $-177M | $-9M | · | $76M | $140M | $-132M | · | $-209M | $-587M | $-565M | · | $-778M | $-602M | $-393M | · | $33M | |
| Market Cap | $430M | $430M | · | $465M | $343M | $265M | · | $452M | $361M | $133M | · | $176M | $381M | $522M | · | $1.05B | |
| Enterprise Value | $872M | $843M | · | $882M | $743M | $781M | · | $965M | $1.57B | $1.42B | · | $1.36B | $1.65B | $2.44B | · | $1.88B | |
| P/E | -2.4 | -43.7 | · | 6.2 | 2.5 | -1.9 | · | -2.1 | -0.6 | -0.2 | · | -0.2 | -0.6 | -1.3 | · | 52.5 | |
| P/S | 0.6 | 0.6 | · | 0.6 | 0.4 | 0.3 | · | 0.4 | 0.3 | 0.1 | · | 0.2 | 0.4 | 0.5 | · | 0.7 | |
| P/B | 1.3 | 0.8 | · | 0.8 | 0.6 | 0.5 | · | 0.9 | 0.9 | 0.2 | · | 0.3 | 0.4 | 0.4 | · | 0.7 | |
| P / Tangible Book | 5.4 | 8.2 | · | 3.6 | 5.1 | 3.9 | · | · | · | 1.2 | · | 1.5 | 2.6 | 1.4 | · | 2.1 | |
| P / Cash Flow | · | -12.7 | · | · | · | -23.6 | · | · | · | -2.1 | · | · | · | -2.8 | · | · | |
| EV / Revenue | 1.1 | 1.2 | · | 1.1 | 0.9 | 0.8 | · | 0.9 | 1.4 | 1.2 | · | 1.2 | 1.5 | 2.5 | · | 1.3 | |
| Earnings Yield | -41.3% | -2.3% | · | 16.2% | 40.4% | -53.1% | · | -48.5% | -164.1% | -433.6% | · | -449.1% | -162.5% | -75.7% | · | 1.9% |
Período más reciente a la izquierda · valores nulos mostrados como ·
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2022-09-30 |
|---|---|---|---|---|---|
| Ingresos | $743M | $1.04B | $1.05B | $1.12B | · |
| Margen Bruto % | · | · | 30.3% | 34.3% | · |
| Margen Operativo % | 13.5% | -10.4% | -69.2% | -15.2% | · |
| Beneficio neto | $53M | $-191M | $-760M | $-212M | · |
| EPS Diluido | $0.93 | $-3.60 | $-14.85 | $-4.22 | · |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2022-09-30 |
|---|---|---|---|---|---|
| Deuda / Patrimonio | 1.1 | 1.4 | 2.0 | · | · |
| Ratio corriente | 5.0 | 3.7 | 1.0 | · | · |
| Ratio Rápido | 2.2 | 1.6 | 0.5 | · | · |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2022-09-30 |
|---|---|---|---|---|---|
| Flujo de caja libre | $157M | $36M | $-258M | $-150M | · |
Propietarios institucionales (13F) 210 declarantes · $391.0M total · A fecha de 30 de junio de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Tenedores
210
Valor en tenencia
$391.0M
Nuevas posiciones
31
Posiciones cerradas
24
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 31 (-7 vs trimestre anterior) | 24 (+1 vs trimestre anterior) | 71 (+1 vs trimestre anterior) | 63 (+9 vs trimestre anterior) | +916K |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| VANGUARD GROUP INC | $43 927 428 | 3 553 999 | 11,23% | Acciones |
| BlackRock, Inc. | $39 525 100 | 4 716 599 | 10,11% | Acciones |
| DIMENSIONAL FUND ADVISORS LP | $25 782 865 | 3 076 646 | 6,59% | Acciones |
| STATE STREET CORP | $24 556 367 | 2 929 238 | 6,28% | Acciones |
| AMERICAN CENTURY COMPANIES INC | $23 216 354 | 2 770 448 | 5,94% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $18 426 271 | 2 198 839 | 4,71% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $11 208 910 | 1 337 243 | 2,87% | Acciones |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $10 062 629 | 1 200 791 | 2,57% | Acciones |
| OAK HILL ADVISORS LP | $9 329 772 | 1 113 338 | 2,39% | Acciones |
| MILLENNIUM MANAGEMENT LLC | $8 984 910 | 1 072 185 | 2,30% | Acciones |
| AQR CAPITAL MANAGEMENT LLC | $8 724 846 | 1 041 151 | 2,23% | Acciones |
| GOLDMAN SACHS GROUP INC | $8 676 828 | 1 035 421 | 2,22% | Acciones |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $8 626 129 | 1 029 371 | 2,21% | Acciones |
| D. E. Shaw & Co., Inc. | $7 542 905 | 900 108 | 1,93% | Acciones |
| Russell Investments Group, Ltd. | $7 202 462 | 859 482 | 1,84% | Acciones |
| FEDERATED HERMES, INC. | $6 964 828 | 831 125 | 1,78% | Acciones |
| PRUDENTIAL FINANCIAL INC | $6 753 400 | 805 895 | 1,73% | Acciones |
| Prescott Group Capital Management, L.L.C. | $6 475 821 | 772 771 | 1,66% | Acciones |
| RENAISSANCE TECHNOLOGIES LLC | $5 725 610 | 683 247 | 1,46% | Acciones |
| NORTHERN TRUST CORP | $5 207 944 | 621 473 | 1,33% | Acciones |
| Allianz Asset Management GmbH | $4 556 885 | 543 781 | 1,17% | Acciones |
| PALISADE CAPITAL MANAGEMENT, LP | $4 316 191 | 515 059 | 1,10% | Acciones |
| NEW YORK STATE COMMON RETIREMENT FUND | $4 306 516 | 513 904 | 1,10% | Acciones |
| TWO SIGMA INVESTMENTS, LP | $4 091 820 | 488 284 | 1,05% | Acciones |
| MORGAN STANLEY | $3 936 225 | 469 715 | 1,01% | Acciones |
| Prosight Management, LP | $3 854 398 | 459 952 | 0,99% | Acciones |
| Trexquant Investment LP | $3 753 050 | 447 858 | 0,96% | Acciones |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC | $3 690 745 | 440 423 | 0,94% | Acciones |
| UBS Group AG | $3 067 172 | 366 011 | 0,78% | Acciones |
| Connor, Clark & Lunn Investment Management Ltd. | $2 966 378 | 353 983 | 0,76% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $2 863 614 | 341 720 | 0,73% | Acciones |
| PANAGORA ASSET MANAGEMENT INC | $2 757 523 | 329 060 | 0,71% | Acciones |
| Values First Advisors, Inc. | $2 526 468 | 301 488 | 0,65% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $2 420 144 | 288 800 | 0,62% | Opción de compra |
| GLOBEFLEX CAPITAL L P | $2 022 077 | 241 298 | 0,52% | Acciones |
| Bank of New York Mellon Corp | $1 840 760 | 219 661 | 0,47% | Acciones |
| FMR LLC | $1 794 733 | 214 169 | 0,46% | Acciones |
| Brandywine Global Investment Management, LLC | $1 610 632 | 130 310 | 0,41% | Acciones |
| DEUTSCHE BANK AG\ | $1 591 513 | 189 918 | 0,41% | Acciones |
| Morse Asset Management, Inc | $1 536 339 | 183 334 | 0,39% | Acciones |
| WOLVERINE ASSET MANAGEMENT LLC | $1 465 939 | 174 933 | 0,37% | Acciones |
| FRANKLIN RESOURCES INC | $1 398 144 | 166 843 | 0,36% | Acciones |
| Y-Intercept (Hong Kong) Ltd | $1 390 066 | 165 879 | 0,36% | Acciones |
| ARISTEIA CAPITAL, L.L.C. | $1 355 490 | 161 753 | 0,35% | Acciones |
| BANK OF AMERICA CORP /DE/ | $1 275 596 | 152 219 | 0,33% | Acciones |
| WELLINGTON MANAGEMENT GROUP LLP | $1 273 476 | 151 966 | 0,33% | Acciones |
| Squarepoint Ops LLC | $1 240 374 | 148 016 | 0,32% | Acciones |
| CREDIT AGRICOLE S A | $1 225 994 | 146 300 | 0,31% | Acciones |
| Invesco Ltd. | $1 224 024 | 146 065 | 0,31% | Acciones |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $1 028 000 | 122 700 | 0,26% | Acciones |
Activistas y propietarios del %+ 5 1 tenencia
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| Emergent BioSolutions Inc. | 23 de agosto de 2010 | · | Presentación inicial | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Informantes de la empresa 48 insiders · 12 directivos · 11 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Daniel Abdun-Nabi | CEO | 4 de marzo de 2019 S | 142 617 | 0 | 0 | $0 |
| Richard S Lindahl | EVP, Chief Financial Officer | 8 de junio de 2026 F | 374 083 | 0 | 0 | $0 |
| Don R Elsey | Chief Financial Officer | 13 de marzo de 2012 A | 26 614 | 0 | 0 | $0 |
| Paul Anthony Williams | SVP, Products Business | 1 de julio de 2026 S | 159 098 | 0 | 2 | $-58 960 |
| William Hartzel | SVP, Bioservices | 8 de junio de 2026 F | 185 558 | 0 | 0 | $0 |
| Coleen Glessner | EVP, Quality & Ethics, and CPL | 8 de junio de 2026 F | 202 201 | 0 | 1 | $-306 080 |
| Simon C Lowry | SVP, R&D, CMO | 29 de abril de 2026 A | 177 914 | 0 | 0 | $0 |
| Jessica Perl | SVP, General Counsel, Corp Sec | 29 de abril de 2026 A | 165 286 | 0 | 0 | $0 |
| Barry Labinger | EVP, Biosciences Div. | 13 de noviembre de 2015 S | 25 182 | 0 | 0 | $0 |
| Steven Chatfield | EVP, BioSciences | 14 de marzo de 2013 F | 28 000 | 0 | 0 | $0 |
| Kyle Keese | EVP, BioSciences Division | 15 de marzo de 2011 A | 18 759 | 0 | 0 | $0 |
| Stephen Lockhart | SVP Product Development | 11 de noviembre de 2010 M | 6 980 | 0 | 0 | $0 |
| Kathryn C Zoon | Consejero | 30 de abril de 2026 A | 79 941 | 0 | 2 | $-144 453 |
| Donald W Degolyer | Consejero | 30 de abril de 2026 A | 129 721 | 0 | 3 | $-317 617 |
| Sujata Tyagi Dayal | Consejero | 30 de abril de 2026 A | 100 563 | 0 | 3 | $-201 130 |
| Neal Franklin Fowler | Consejero | 30 de abril de 2026 A | 160 847 | 0 | 0 | $0 |
| Marvin L White | Consejero | 30 de abril de 2026 A | 113 839 | 0 | 0 | $0 |
| John D Fowler JR | Consejero | 30 de abril de 2026 A | 30 350 | 0 | 0 | $0 |
| Fuad El-Hibri | Consejero | 3 de diciembre de 2021 J | 206 434 | 0 | 0 | $0 |
| Seamus Mulligan | Consejero | 19 de marzo de 2019 A | 56 141 | 0 | 0 | $0 |
| John Niederhuber | Consejero | 18 de mayo de 2016 D | 30 300 | 0 | 0 | $0 |
| Shahzad Malik | Consejero | 14 de junio de 2007 A | · | 0 | 0 | $0 |
| Intervac, L.L.C. | Propietario del 10% | 18 de septiembre de 2012 J | 4 344 250 | 0 | 0 | $0 |
| BioPharm, L.L.C. | Propietario del 10% | 27 de mayo de 2010 J | 2 265 043 | 0 | 0 | $0 |
| Microscience Investments LTD | Propietario del 10% | 8 de marzo de 2007 J | 0 | 0 | 0 | $0 |
| Zsolt Harsanyi | · | 30 de abril de 2026 A | 149 076 | 0 | 0 | $0 |
| Ronald Richard | · | 30 de abril de 2026 A | 123 761 | 0 | 2 | $-263 101 |
| Keith Katkin | · | 30 de abril de 2026 A | 96 294 | 0 | 1 | $-128 183 |
| Joseph C Papa | · | 29 de abril de 2026 A | 493 153 | 0 | 0 | $0 |
| Louis W Sullivan | · | 30 de abril de 2025 A | 139 098 | 0 | 0 | $0 |
| Jennifer Lynne Fox | · | 11 de julio de 2024 A | 186 382 | 0 | 0 | $0 |
| Adam Havey | · | 9 de junio de 2023 A | 174 398 | 0 | 0 | $0 |
| Robert Kramer | · | 9 de junio de 2023 A | 506 059 | 0 | 0 | $0 |
| Jerome M Hauer | · | 25 de mayo de 2023 A | 57 508 | 0 | 0 | $0 |
| Katherine Strei | · | 28 de febrero de 2023 F | 62 824 | 0 | 0 | $0 |
| Atul Saran | · | 28 de febrero de 2023 F | 86 645 | 0 | 0 | $0 |
| George A Joulwan | · | 26 de mayo de 2022 A | 40 244 | 0 | 0 | $0 |
| Karen L. Smith | · | 7 de mayo de 2021 F | 11 888 | 0 | 0 | $0 |
| Sean Kirk | · | 31 de marzo de 2021 F | 17 776 | 0 | 0 | $0 |
| Sue Bailey | · | 4 de marzo de 2021 S | 24 427 | 0 | 0 | $0 |
| Denise Esposito | · | 10 de marzo de 2009 A | 500 | 0 | 0 | $0 |
| Biologika, L.L.C. | · | 4 de junio de 2008 S | 1 399 764 | 0 | 0 | $0 |
| Joe M Allbaugh | · | 21 de mayo de 2008 A | · | 0 | 0 | $0 |
| Michigan Biologic Products, Inc. | · | 28 de marzo de 2008 S | 1 269 390 | 0 | 0 | $0 |
| Mauro Gibellini | · | 4 de junio de 2007 S | 0 | 0 | 0 | $0 |
| Thomas Zink | · | 17 de mayo de 2007 P | 1 000 | 0 | 0 | $0 |
| Edward Arcuri | · | 8 de mayo de 2007 M | 76 722 | 0 | 0 | $0 |
| Robert Calvin Myers | · | 20 de noviembre de 2006 C | · | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Propiedad de ETFs Mantenido por 61 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| EWO · iShares, Inc. | 23,05% | 335 709 SH | 11 de septiembre de 2026 | Diario |
| EUFN · iShares Trust | 1,19% | 353 714 SH | 11 de septiembre de 2026 | Diario |
| MTRA · Invesco Actively Managed Exchange-T… | 1,14% | 11 292 SH | 1 de octubre de 2026 | Diario |
| MYLD · Cambria ETF Trust | 0,87% | 41 046 NS | 31 de julio de 2026 | N-PORT |
| PIZ · Invesco Exchange-Traded Fund Trust … | 0,69% | 33 118 SH | 1 de octubre de 2026 | Diario |
| EZU · iShares, Inc. | 0,57% | 390 787 SH | 11 de septiembre de 2026 | Diario |
| BSJS · Invesco Exchange-Traded Self-Indexe… | 0,40% | 3 381 000 | 1 de octubre de 2026 | Diario |
| DMXF · iShares Trust | 0,40% | 26 552 SH | 11 de septiembre de 2026 | Diario |
| IEV · iShares Trust | 0,32% | 37 421 SH | 11 de septiembre de 2026 | Diario |
| IVLU · iShares Trust | 0,31% | 102 055 SH | 11 de septiembre de 2026 | Diario |
| IXG · iShares Trust | 0,28% | 13 907 SH | 11 de septiembre de 2026 | Diario |
| IEUR · iShares Trust | 0,28% | 179 129 SH | 11 de septiembre de 2026 | Diario |
| IMTM · iShares Trust | 0,25% | 77 739 SH | 11 de septiembre de 2026 | Diario |
| VGK · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,24% | 673 051 SH | 19 de agosto de 2026 | Diario |
| PABD · iShares Trust | 0,23% | 5 313 SH | 11 de septiembre de 2026 | Diario |
| EFG · iShares Trust | 0,20% | 236 854 SH | 11 de septiembre de 2026 | Diario |
| VYMI · VANGUARD WHITEHALL FUNDS | 0,20% | 312 634 SH | 19 de agosto de 2026 | Diario |
| EFA · iShares Trust | 0,20% | 1 097 211 SH | 11 de septiembre de 2026 | Diario |
| EFV · iShares Trust | 0,20% | 436 714 SH | 11 de septiembre de 2026 | Diario |
| IEFA · iShares Trust | 0,17% | 2 312 794 SH | 11 de septiembre de 2026 | Diario |
| IDEV · iShares Trust | 0,15% | 343 523 SH | 11 de septiembre de 2026 | Diario |
| ESGD · iShares Trust | 0,14% | 123 676 SH | 11 de septiembre de 2026 | Diario |
| ACWX · iShares Trust | 0,12% | 101 401 SH | 11 de septiembre de 2026 | Diario |
| PXF · Invesco Exchange-Traded Fund Trust … | 0,11% | 23 661 SH | 1 de octubre de 2026 | Diario |
| VEA · VANGUARD TAX-MANAGED FUNDS | 0,11% | 2 737 509 SH | 19 de agosto de 2026 | Diario |
| VSGX · VANGUARD WORLD FUND | 0,11% | 56 354 SH | 19 de agosto de 2026 | Diario |
| IXUS · iShares Trust | 0,10% | 431 754 SH | 11 de septiembre de 2026 | Diario |
| VEU · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,09% | 655 464 SH | 19 de agosto de 2026 | Diario |
| LABU · Direxion Shares ETF Trust | 0,08% | 57 978 NS | 31 de julio de 2026 | N-PORT |
| VXUS · VANGUARD STAR FUNDS | 0,08% | 4 120 164 SH | 19 de agosto de 2026 | Diario |
| IWC · iShares Trust | 0,07% | 175 885 SH | 11 de septiembre de 2026 | Diario |
| TOK · iShares Trust | 0,05% | 841 SH | 11 de septiembre de 2026 | Diario |
| URTH · iShares, Inc. | 0,05% | 28 175 SH | 11 de septiembre de 2026 | Diario |
| ACWI · iShares Trust | 0,04% | 100 105 SH | 11 de septiembre de 2026 | Diario |
| IMFL · Invesco Exchange-Traded Self-Indexe… | 0,04% | 2 979 SH | 1 de octubre de 2026 | Diario |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,03% | 242 129 SH | 19 de agosto de 2026 | Diario |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,03% | 45 382 SH | 19 de agosto de 2026 | Diario |
| DFSV · Dimensional ETF Trust | 0,03% | 304 251 NS | 31 de julio de 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,03% | 105 903 SH | 1 de octubre de 2026 | Diario |
| PWS · Pacer Funds Trust | 0,02% | 792 NS | 31 de julio de 2026 | N-PORT |
| IBB · iShares Trust | 0,02% | 366 188 SH | 11 de septiembre de 2026 | Diario |
| DFAT · Dimensional ETF Trust | 0,02% | 374 907 NS | 31 de julio de 2026 | N-PORT |
| CRBN · iShares Trust | 0,02% | 1 504 SH | 11 de septiembre de 2026 | Diario |
| RSSL · Global X Funds | 0,01% | 24 878 NS | 31 de julio de 2026 | N-PORT |
| IWM · iShares Trust | 0,01% | 1 357 340 SH | 11 de septiembre de 2026 | Diario |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 299 394 SH | 19 de agosto de 2026 | Diario |
| VHT · VANGUARD WORLD FUND | 0,01% | 151 590 SH | 19 de agosto de 2026 | Diario |
| DFAS · Dimensional ETF Trust | 0,01% | 170 332 NS | 31 de julio de 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,00% | 2 757 NS | 31 de julio de 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 140 649 NS | 31 de julio de 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 5 377 NS | 31 de julio de 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,00% | 2 661 NS | 31 de julio de 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 18 981 NS | 31 de julio de 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 10 026 NS | 31 de julio de 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 56 305 SH | 11 de septiembre de 2026 | Diario |
| IWV · iShares Trust | 0,00% | 14 557 SH | 4 de septiembre de 2026 | Diario |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 592 580 SH | 19 de agosto de 2026 | Diario |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1 554 116 SH | 19 de agosto de 2026 | Diario |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 4 439 SH | 19 de agosto de 2026 | Diario |
| IWN · iShares Trust | · | 499 316 SH | 11 de septiembre de 2026 | Diario |
| SMLF · iShares Trust | · | 279 031 SH | 11 de septiembre de 2026 | Diario |
EBS Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
calificación · 7 analistas
COMPRA
Objetivo mediano
$11.00
+73,8%
1 14,3%
Compra fuerte
4 57,1%
Compra
1 14,3%
Mantener
1 14,3%
Venta
0 0,0%
Venta fuerte
Precio objetivo a 12 meses
2 analistas · 2026-09-28Objetivo medio $11.00 +73,8%
← Por Debajo de Todos los Objetivos
Precio Actual $6.33
Mín$10.00
Media$11.00
Máx$12.00
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
Base del ejercicio fiscal, precios al cierre del último ejercicio fiscal de cada empresa.
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| EBS | $644M | 13.3 | -28.8% | 7.1% | 9.9% | · |
| SRZN | · | · | · | · | · | · |
| CYPH | $97M | 16.6 | · | · | 6.1% | · |
| ARTV | · | -1.3 | -99.2% | · | · | · |
| SCTX | · | · | · | · | · | · |
| BNTC | $460M | -13.7 | · | · | -25.0% | · |
| BBOT | $1.00B | -2.9 | · | · | -146.2% | · |
| CABA | $220M | -1.0 | · | · | -115.5% | · |
| LRMR | $317M | -2.2 | · | · | -167.4% | · |
Últimas noticias Noticias recientes que mencionan a esta empresa
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
Seleccione las métricas que le importan: haga clic en el + junto a cualquier fila en Fundamentales completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Fuente: SEC 10-Q presentada el Ago 6, 2026